Original Research
Accepted on 05 Sep 2025
On-Treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma (HCC) treated with atezolizumab and bevacizumab provides prognostic information
in Cancer Immunity and Immunotherapy
- 521 views